HSG

HSG, formerly known as Sequoia Capital China, is a global venture capital and private equity firm, managing over USD 55 billion across various funds. Established in 2005, HSG invests in technology, healthcare, and consumer sectors, with a focus on seed, venture, growth, buyout, and infrastructure stages. The firm has backed over 1,500 companies, with more than 160 listed on public exchanges and over 140 achieving unicorn status. HSG operates globally, with offices in Hong Kong, Shanghai, Beijing, Shenzhen, London, Tokyo, and Singapore, providing extensive resources and industry expertise to its portfolio companies.

Rohit Agarwal

Managing Director

Mohit Bhatnagar

Managing Director

Wang Chenyu

Vice President

Sakshi Chopra

Managing Director

Raghavv Garg

Analyst

Pushpak Kedia

Vice President

Sunint Khurana

Analyst

Saksham Mittal

Analyst

Ishaan Mittal

Managing Director

Abhishek Mohan

Principal

Javier Ng

Associate

Enita Pu

Partner

Wendy Qian

Analyst

Haim Sadger

Partner

Yoav Shaked

Partner

Johan Surani

Vice President

Vedant Trivedi

Associate

Aradhita Tuli

Investment Analyst

Pavel Vyhnalek

Operating Partner

Fu Xin

Partner

Past deals in Washington

Zuper

Series A in 2022
Zuper, Inc. is an information technology company based in Sammamish, Washington, founded in 2016. It specializes in developing a comprehensive field service management platform that enhances collaboration and efficiency for field and remote workforces. The platform provides a suite of tools including work order management, intelligent scheduling, timesheet management, live location tracking, and estimation software. Zuper's solution is designed to integrate seamlessly with various applications and customer relationship management systems, allowing organizations in industries such as cleaning, electrical, plumbing, internet services, and landscaping to optimize their operations. By modernizing field operations, Zuper helps service businesses expand rapidly while improving customer experiences through robust reporting and analytics.

dMed

Series C in 2021
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.

Outreach

Series G in 2021
Outreach Inc. is a Seattle-based company that specializes in sales engagement solutions designed to enhance revenue growth by streamlining customer interactions across various channels, including email, voice, and social media. Founded in 2011, Outreach offers a platform that utilizes machine learning to automate repetitive sales tasks, optimize communication, and provide real-time insights based on buyer sentiment. Its features include account-based sales solutions, task management, and comprehensive tracking of email and activity metrics. Outreach's clientele encompasses major companies such as Zoom, Okta, Adobe, and Microsoft, which depend on its technology to improve sales efficiency and effectiveness. The company also maintains an office in London, United Kingdom.

dMed

Series C in 2020
dMed Company Limited, also known as dMed Biopharmaceutical Co., Ltd., is a clinical contract research organization based in Shanghai, China. Established in 2016, dMed specializes in offering a comprehensive range of services to support the development of medicines and medical devices. Its offerings include consulting, clinical operations, biostatistics and programming, data management, pharmacovigilance, clinical science and medical affairs, quality assurance, and regulatory affairs and strategy. The company serves a diverse clientele, including biopharmaceutical and medical device companies, and aims to establish itself as a prominent international brand in the field of drug innovation services and solutions.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.